NCI at AACR COVID-19 and Cancer

SUNDAY, JULY 19

Join the NCI as we showcase our research and programs at the American Association for Cancer Research (AACR) Virtual Meeting: COVID-19 and Cancer (July 20-22, 2020). Individuals wishing to attend the virtual meeting must register online.

This three-day conference will focus on the effects of COVID-19 on cancer care and research and the unique position of cancer researchers to influence the trajectory and long-term implications of the pandemic.

Tomorrow's Sessions Featuring NCI Leaders and Experts:

NCI Deputy Director James Doroshow, MD, will participate in a forum discussion titled, “Regulatory and Operational Implications of Cancer Clinical Trial Changes During COVID-19.”

Join this session on Monday, July 20, 1:05-2:05 p.m. EDT

Cancer researcher and Director of NCI's Center for Cancer Genomics, Louis M. Staudt, MD, PhD, will present his session, "Inhibition of Bruton Tyrosine Kinase in Patients with Severe COVID-19," during the Symposium on Cancer Drug Repurposing to Treat COVID-19.

Join this session on Monday, July 20, 2:20-4:35 p.m. EDT

Save the Dates for These Upcoming Leadership Presentations:

NCI Director Ned Sharpless, MD, will address attendees during the closing roundtable session titled “Returning to Cancer Research During COVID-19,” where he will discuss NCI’s role in ensuring cancer research progress amid a pandemic. The roundtable, which is being moderated by Elizabeth Jaffee, MD, of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, will include a panel discussion and Q&A.

Join this session on Wednesday, July 22, 4:35-6:00 p.m. EDT

NCI Principal Deputy Director Douglas Lowy, MD, will present “When Cancer Research Goes Viral” during Symposium 8: COVID-19 Diagnostics Development.

Join this session on Tuesday, July 21, 2:20-4:20 p.m. EDT

Applications for SeroNet Research Funding Closes July 22

NCI supports scientists and research projects through a rigorous grant application and peer-review process. There are several active requests for applications, including new emergency funding for a Serological Sciences Network for COVID-19 (SeroNet) research project that closes on Wednesday, July 22. To learn more about the scientific scope and application details related to SeroNet, view the slides from the pre-application webinar and the list of frequently asked questions.

Connect with NCI

Stay connected through our daily emails or by visiting our NCI at AACR: COVID-19 and Cancer webpage to learn more about the upcoming sessions and available resources.